Interpretable HER2 scoring by evaluating clinical Guidelines through a weakly supervised, constrained Deep Learning Approach

no code implementations • 17 Nov 2022 • Manh Dan Pham, Cyprien Tilmant, Stéphanie Petit, Isabelle Salmon, Saima Ben Hadj, Rutger H. J. Fick

The evaluation of the Human Epidermal growth factor Receptor-2 (HER2) expression is an important prognostic biomarker for breast cancer treatment selection.